• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对原发性胆汁性胆管炎伴瘙痒患者的患者报告结局指标的开发与适配

Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis.

作者信息

Martin Mona L, Stassek Larissa, Blum Steven I, Joshi Ashish V, Jones David

机构信息

Health Research Associates, Inc., 6505 216th St. SW, Suite 105, Mountlake Terrace, WA, 98043, USA.

, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA, 19426, USA.

出版信息

J Patient Rep Outcomes. 2019 Jan 15;3(1):2. doi: 10.1186/s41687-018-0090-1.

DOI:10.1186/s41687-018-0090-1
PMID:30645706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6333594/
Abstract

PURPOSE

To conduct qualitative interviews to evaluate and refine the Itch Diary (ID) and weekly version of the PBC-40 in patients with itching associated with primary biliary cholangitis (PBC).

METHODS

Twenty adults with self-reported PBC diagnoses and recent/ongoing itching of at least moderate intensity participated in face-to-face qualitative combined concept elicitation (CE) interviews and cognitive interviews after completing the morning and evening versions of the ID and weekly version of the PBC-40. These questionnaires were evaluated to confirm saturation of concepts of interest and cognitively test the English language versions of the measures in patients with PBC in the US and Canada. Transcripts were organized into descriptions of PBC-related symptoms and symptom-related impacts using a structured coding framework. Two waves of interviews were conducted; revisions made after wave 1 were further tested in wave 2.

RESULTS

Interview results confirmed the relevance of concepts presented in the PBC-40 and ID to patients' experiences. Saturation of concept was achieved. Itching-related signs and symptoms (46%) were the most commonly expressed symptom concept in the CE interviews followed by energy-related (14%) and additional signs/symptoms (13%). Several changes to the ID were made in response to cognitive interview results. Changes to the PBC-40 included adaptations from British to North American English, and the appropriateness of a 7-day recall period was confirmed.

CONCLUSIONS

Relevance of the symptom and impact concepts in the ID to measure PBC-related itch were confirmed. Adaptation of the PBC-40 to a weekly recall period and for North American English was successful.

摘要

目的

进行定性访谈,以评估和完善原发性胆汁性胆管炎(PBC)患者的瘙痒日记(ID)和PBC-40的每周版本。

方法

20名自我报告患有PBC诊断且近期/正在经历至少中度强度瘙痒的成年人,在完成ID的早晚版本和PBC-40的每周版本后,参加了面对面的定性联合概念激发(CE)访谈和认知访谈。对这些问卷进行评估,以确认感兴趣概念的饱和度,并在美国和加拿大的PBC患者中对这些测量方法的英语版本进行认知测试。使用结构化编码框架将访谈记录整理成与PBC相关症状和症状相关影响的描述。进行了两轮访谈;第一轮后做出的修订在第二轮中进一步测试。

结果

访谈结果证实了PBC-40和ID中呈现的概念与患者经历的相关性。实现了概念的饱和度。在CE访谈中,与瘙痒相关的体征和症状(46%)是最常表达的症状概念,其次是与能量相关的(14%)和其他体征/症状(13%)。根据认知访谈结果对ID进行了几处修改。对PBC-40的修改包括从英式英语改编为北美英语,并确认了7天回忆期的适宜性。

结论

证实了ID中症状和影响概念与测量PBC相关瘙痒的相关性。PBC- 的适应每周回忆期和北美英语改编成功。40

相似文献

1
Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis.针对原发性胆汁性胆管炎伴瘙痒患者的患者报告结局指标的开发与适配
J Patient Rep Outcomes. 2019 Jan 15;3(1):2. doi: 10.1186/s41687-018-0090-1.
2
Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial.在 2b 期 GLIMMER 试验中原发性胆汁性胆管炎参与者中瘙痒与睡眠的关系。
J Patient Rep Outcomes. 2024 Jun 12;8(1):60. doi: 10.1186/s41687-024-00722-y.
3
Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.局灶节段性肾小球硬化患者报告结局测量工具的开发:症状日记和症状影响问卷。
Am J Kidney Dis. 2017 Oct;70(4):532-540. doi: 10.1053/j.ajkd.2017.04.023. Epub 2017 Jun 26.
4
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.纤维瘤瘙痒症(FITCH)在纤维性胆管病变中的疗效:一项双盲、随机、安慰剂对照试验。
Gastroenterology. 2021 Feb;160(3):734-743.e6. doi: 10.1053/j.gastro.2020.10.001. Epub 2020 Oct 5.
5
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.Seladelpar 改善了原发性胆汁性胆管炎患者的瘙痒、睡眠和疲劳等症状,并降低了血清胆汁酸水平。
Liver Int. 2022 Jan;42(1):112-123. doi: 10.1111/liv.15039. Epub 2021 Aug 26.
6
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.回肠胆汁酸转运蛋白抑制剂 GSK2330672 对原发性胆汁性胆管炎瘙痒的影响:一项双盲、随机、安慰剂对照、交叉、2a 期研究。
Lancet. 2017 Mar 18;389(10074):1114-1123. doi: 10.1016/S0140-6736(17)30319-7. Epub 2017 Feb 8.
7
Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.非小细胞肺癌症状评估问卷(NSCLC-SAQ)的质性开发与内容效度:一项患者报告结局工具
Clin Ther. 2016 Apr;38(4):794-810. doi: 10.1016/j.clinthera.2016.03.012. Epub 2016 Apr 1.
8
Pruritus in primary biliary cholangitis is under-recorded in patient medical records.原发性胆汁性胆管炎患者的瘙痒症在病历中记录不足。
BMJ Open Gastroenterol. 2024 Mar 27;11(1):e001287. doi: 10.1136/bmjgast-2023-001287.
9
Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.开发患者和观察者报告的 PRUCISION 工具,以评估患有胆汁淤积性肝病的儿科患者的瘙痒和睡眠障碍。
Adv Ther. 2022 Nov;39(11):5126-5143. doi: 10.1007/s12325-022-02261-8. Epub 2022 Sep 6.
10
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.瘙痒在英国原发性胆汁性胆管炎患者中很常见,但治疗不足。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1379-1387.e3. doi: 10.1016/j.cgh.2018.12.007. Epub 2018 Dec 14.

引用本文的文献

1
Psychometric validation of the Worst Itch Numerical Rating Scale (WI-NRS) and other patient-reported outcome measures for assessing severity and impact of pruritus in patients with primary biliary cholangitis.原发性胆汁性胆管炎患者瘙痒严重程度和影响评估中最差瘙痒数字评定量表(WI-NRS)及其他患者报告结局指标的心理测量学验证
Orphanet J Rare Dis. 2025 Jul 31;20(1):390. doi: 10.1186/s13023-025-03798-x.
2
Understanding data visualization techniques in qualitative studies used to develop and validate patient-reported outcome measures: a targeted literature review.理解用于开发和验证患者报告结局指标的定性研究中的数据可视化技术:一项针对性文献综述。
Qual Life Res. 2025 Apr 25. doi: 10.1007/s11136-025-03964-5.
3
Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial.在 2b 期 GLIMMER 试验中原发性胆汁性胆管炎参与者中瘙痒与睡眠的关系。
J Patient Rep Outcomes. 2024 Jun 12;8(1):60. doi: 10.1186/s41687-024-00722-y.
4
Systematic Review of the Effect of a One-Day Versus Seven-Day Recall Duration on Patient Reported Outcome Measures (PROMs).一天与七天回忆间隔对患者报告结局测量(PROMs)效果的系统评价。
Patient. 2023 May;16(3):201-221. doi: 10.1007/s40271-022-00611-w. Epub 2023 Feb 14.
5
A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.原发性胆汁性胆管炎和原发性硬化性胆管炎患者报告结局的系统评价
Hepatol Commun. 2020 Aug 1;4(10):1502-1515. doi: 10.1002/hep4.1567. eCollection 2020 Oct.

本文引用的文献

1
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.英国胃肠病学会/英国原发性胆汁性胆管炎治疗和管理指南。
Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.
2
Scale development with small samples: a new application of longitudinal item response theory.小样本量下的量表编制:纵向项目反应理论的新应用。
Qual Life Res. 2018 Jul;27(7):1721-1734. doi: 10.1007/s11136-018-1801-z. Epub 2018 Feb 8.
3
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.原发性胆汁性胆管炎的发病率上升和治疗后死亡率降低。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23.
4
A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis.原发性胆汁性肝硬化中胆汁淤积性瘙痒管理的系统方法。
Frontline Gastroenterol. 2016 Jul;7(3):158-166. doi: 10.1136/flgastro-2015-100618. Epub 2015 Aug 26.
5
Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.原发性胆汁性胆管炎:其病理特征与免疫病理机制
J Med Invest. 2017;64(1.2):7-13. doi: 10.2152/jmi.64.7.
6
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.回肠胆汁酸转运蛋白抑制剂 GSK2330672 对原发性胆汁性胆管炎瘙痒的影响:一项双盲、随机、安慰剂对照、交叉、2a 期研究。
Lancet. 2017 Mar 18;389(10074):1114-1123. doi: 10.1016/S0140-6736(17)30319-7. Epub 2017 Feb 8.
7
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial.BAT117213:抑制回肠胆汁酸转运体(IBAT)治疗原发性胆汁性肝硬化瘙痒症:一项随机对照试验的研究方案
BMC Gastroenterol. 2016 Jul 19;16(1):71. doi: 10.1186/s12876-016-0481-9.
8
Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study.原发性胆汁性肝硬化对生活质量感知的影响:英国 PBC 全国研究。
Hepatology. 2013 Jul;58(1):273-83. doi: 10.1002/hep.26365.
9
The 5-D itch scale: a new measure of pruritus.5-D 瘙痒量表:一种新的瘙痒测量方法。
Br J Dermatol. 2010 Mar;162(3):587-93. doi: 10.1111/j.1365-2133.2009.09586.x. Epub 2009 Dec 1.
10
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.加拿大某健康地区原发性胆汁性肝硬化的流行病学及自然史:一项基于人群的研究。
Hepatology. 2009 Dec;50(6):1884-92. doi: 10.1002/hep.23210.